Results 201 to 210 of about 76,948 (211)

Enzymatic Activities of CYP3A4 Allelic Variants on Quinine 3-Hydroxylation In Vitro

Frontiers in Pharmacology, 2019
Xiao-Yang Zhou, Chen-Chen Wang, Qian Liu   +2 more
exaly  

The Intestinal First-pass Metabolism of Substrates of CYP3A4 and P-glycoprotei—Quantitative Analysis Based on Information from the Literature

Drug Metabolism and Pharmacokinetics, 2003
Akihiro Hisaka, Kiyomi Itô
exaly  

Ile118Val genetic polymorphism of CYP3A4 and its effects on lipid-lowering efficacy of simvastatin in Chinese hyperlipidemic patients

European Journal of Clinical Pharmacology, 2005
An Wang, Zhi-Rong Tan, Gan Zhou
exaly  

Functional characterization of 27 CYP3A4 protein variants to metabolize regorafenib in vitro

Basic and Clinical Pharmacology and Toxicology, 2019
Ying-Hui Li, Qian-Meng Lin, Ni-Hong Pang   +2 more
exaly  

Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components

British Journal of Clinical Pharmacology, 1999
D J Back
exaly  

Impact of CYP3A4 Genotype on Voriconazole Exposure

Clinical Pharmacology & Therapeutics, 2017
Thomas, Duflot, Aurélien, Schrapp, Jérémy, Bellien, Fabien, Lamoureux   +3 more
openaire   +2 more sources

CYP3A4

openaire   +1 more source

CYP3A4*22 and CYP3A Combined Genotypes Both Correlate With Tacrolimus Disposition in Pediatric Heart Transplant Recipients

Pharmacogenomics, 2013
Ron Hn van Schaik, Laure Elens, Offie P Soldin   +2 more
exaly  

Prediction of response to docetaxel by immunohistochemical analysis of CYP3A4 expression in human breast cancers

Breast Cancer, 2005
Yasuo Miyoshi, Tetsuya Taguchi
exaly  

Bufalin inhibits CYP3A4 activity in vitro and in vivo

Acta Pharmacologica Sinica, 2009
exaly